SEC 13F Intelligence

M28 Capital Management LP / BBIO

M28 Capital Management LP’s Bridgebio Pharma Inc Position

Does M28 Capital Management LP own Bridgebio Pharma Inc (BBIO)? Not currently — the last reported position was 121.2K shares worth $4M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q1 2025
Shares
121.2K
% of Portfolio
+5.74%
Quarters Held
14
position exited

Position History BBIO

Reported value by quarter
Q4 ’21: $8MQ4 ’21Q1 ’22: $5MQ2 ’22: $4MQ2 ’22Q3 ’22: $5MQ4 ’22: $3MQ4 ’22Q1 ’23: $5MQ2 ’23: $3MQ2 ’23Q3 ’23: $3MQ4 ’23: $5MQ4 ’23Q1 ’24: $4MQ2 ’24: $3MQ2 ’24Q3 ’24: $3MQ4 ’24: $3MQ4 ’24Q1 ’25: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2025121.2K$4M+5.74%
Q4 2024121.2K$3M+3.27%
Q3 2024121.2K$3M+3.39%
Q2 2024121.2K$3M+3.98%
Q1 2024121.2K$4M+2.77%
Q4 2023121.2K$5M+4.05%
Q3 2023121.2K$3M+3.67%
Q2 2023166.2K$3M+3.78%
Q1 2023304.7K$5M+5.71%
Q4 2022419.0K$3M+3.04%
Q3 2022513.3K$5M+5.33%
Q2 2022466.2K$4M+4.75%
Q1 2022466.2K$5M+4.35%
Q4 2021466.2K$8M+6.07%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See M28 Capital Management LP’s full portfolio or all institutional holders of BBIO.